Mizuno Mirei, Nakanishi Ikuo, Matsubayashi Satoko, Imai Kohei, Arai Takuya, Matsumoto Ken-Ichiro, Fukuhara Kiyoshi
School of Pharmaceutical Sciences, Showa University, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo 142-8555, Japan.
Quantitative RedOx Sensing Team (QRST), Department of Basic Medical Sciences for Radiation Damages, National Institute of Radiological Sciences (NIRS), Inage-ku, Chiba 263-8555, Japan.
Bioorg Med Chem Lett. 2017 Feb 15;27(4):1041-1044. doi: 10.1016/j.bmcl.2016.12.067. Epub 2016 Dec 29.
Proanthocyanidin, an oligomer of catechin, is a natural antioxidant and a potent inhibitor of lectin-like oxidized LDL receptor-1, which is involved in the pathogenesis of arteriosclerosis. We synthesized proanthocyanidin analogue 1, in which the geometry of one catechin molecule in procyanidin B3, a dimer of (+)-catechin, is constrained to be planar. The antioxidant activities of the compounds were evaluated in terms of their capacities to scavenge galvinoxyl radicals, and results demonstrate that while procyanidin was 3.8 times more potent than (+)-catechin, the radical scavenging activity of proanthocyanidin analogue 1 was further increased to 1.9 times that of procyanidin B3. This newly designed proanthocyanidin analogue 1 may be a promising lead compound for the treatment of arteriosclerosis and related cerebrovascular diseases.
原花青素是儿茶素的低聚物,是一种天然抗氧化剂,也是凝集素样氧化低密度脂蛋白受体 -1的有效抑制剂,该受体参与动脉粥样硬化的发病机制。我们合成了原花青素类似物1,其中原花青素B3((+)-儿茶素的二聚体)中一个儿茶素分子的几何形状被限制为平面结构。根据化合物清除加尔文氧基自由基的能力评估其抗氧化活性,结果表明,虽然原花青素的效力是(+)-儿茶素的3.8倍,但原花青素类似物1的自由基清除活性进一步提高到原花青素B3的1.9倍。这种新设计的原花青素类似物1可能是治疗动脉粥样硬化及相关脑血管疾病的有前景的先导化合物。